Division of Hematology and Oncology Archive — Page 9 of 16

Portrait of a smiling woman with red hair wearing a black top.
March 18, 2021

EGFR Resisters/LUNGevity fund lung cancer research

Christine Lovly, MD, PhD, associate professor of Medicine in the Division of Hematology and Oncology and Ingram Professor of Cancer Research, is one of two inaugural recipients of the EGFR Resisters/LUNGevity Lung Cancer Research Award.

By Tom Wilemon
A formally dressed woman and man pose together at an indoor event.
February 25, 2021

Gift in memory of Phran Galante boosts lung cancer research

A gift in memory of music industry executive and community philanthropist Phran Galante will support the work of Christine Lovly, MD, PhD, associate professor of Medicine and Ingram Professor of Cancer Research, to improve targeted therapies for lung cancer.

By Tom Wilemon
Three masked researchers stand in a laboratory between workstations, equipment, and shelves of bottles and supplies.
December 22, 2020

Arthritis drug may treat immunotherapy-related heart complication

By Tom Wilemon
Portrait of Cathy Eng, MD, wearing a white medical coat over a pink patterned blouse.
November 18, 2020

New drug for metastatic colorectal cancer enters phase 3 trial

A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center.

By Tom Wilemon
VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
November 10, 2020

Study underscores importance of personalized medicine in kidney cancer

A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions.

By Tom Wilemon
Head-and-shoulders portrait of Brian Rini, MD, wearing a dark suit jacket and white shirt against a gray background.
October 29, 2020

Rini to lead NCI study of COVID-19 in cancer patients

Brian Rini, MD, is leading a study launched by the National Cancer Institute (NCI) that will closely monitor cancer patients who acquire COVID-19 with the goal of providing highly detailed data to guide future care.

By Tom Wilemon